Sign In
Buy CAR
$173.86
+1.48 (+0.86%)
At Close: Jun 03, 2026
Car Shareholders Lost Money? Levi & Korsinsky, LLP Probes Reported Vs.
09:00am, Thursday, 26'th Mar 2026
Avis Budget Group Told Investors Adjusted EBITDA Rose 11% -- But GAAP Results Showed an $856 Million Net Loss Avis Budget Group Told Investors Adjusted EBITDA Rose 11% -- But GAAP Results Showed an $8
CAR INVESTORS LOSE BIG ON Q4 EARNINGS MISS -- LEVI & KORSINSKY, LLP INVESTIGATES
09:00am, Wednesday, 25'th Mar 2026
Avis Budget Group Posts $856 Million Net Loss as Revenue Falls Short of Expectations NEW YORK, March 25, 2026 /PRNewswire/ -- Avis Budget Group (NASDAQ: CAR) shareholders suffered significant losses a
Lyell Immunopharma: Strong Early CAR-T Data, And Now A More Measured Bet
04:37pm, Monday, 23'rd Mar 2026
Lyell Immunopharma is a CAR-T developer with a single pivotal asset, ronde-cel, targeting LBCL and showing superior early efficacy and safety data. Ronde-cel's 93% ORR, 76% CR, and ~18-month mPFS in 3
Avis Budget (CAR) Up 3.8% Since Last Earnings Report: Can It Continue?
12:31pm, Friday, 20'th Mar 2026
Avis Budget (CAR) reported earnings 30 days ago. What's next for the stock?
CAR SHAREHOLDERS LOST MONEY? LEVI & KORSINSKY, LLP PROBES REPORTED VS.
09:00am, Wednesday, 18'th Mar 2026
Avis Budget Group Told Investors Adjusted EBITDA Rose 11% -- But GAAP Results Showed an $856 Million Net Loss NEW YORK, March 18, 2026 /PRNewswire/ -- Avis Budget Group (NASDAQ: CAR) reported adjusted
Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value
09:38am, Tuesday, 17'th Mar 2026
Caribou Biosciences offers the strongest allogeneic CAR-T data to date, with efficacy and safety rivaling approved autologous products. CRBU trades near net cash value, implying the market assigns min
Commercialization ready compound supports a new method of generating highly functional human CAR-T cells for treating infectious diseases and cancer
Poolbeg Pharma adds CAR-T therapy expert to scientific advisory board
03:37am, Thursday, 12'th Mar 2026
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the AIM-listed clinical-stage biopharmaceutical company, has appointed Dr Adrian Kilcoyne to its Scientific Advisory Board, bringing more than 20 y
Crédit Agricole Ille-et-Vilaine : Avis de convocation à l'Assemblée générale mixte du 26 mars 2026 et projet de résolutions
10:03am, Wednesday, 11'th Mar 2026
Caisse régionale de Crédit Agricole Mutuel d'Ille-et-Vilaine, société coopérative à capital variable, agréée en tant qu'établissement de crédit, Siège social : 4, rue Louis Braille - 35136
Car Shareholders Lost Money? Levi & Korsinsky, LLP Probes Reported Vs.
09:00am, Thursday, 05'th Mar 2026
Avis Budget Group Told Investors Adjusted EBITDA Rose 11% -- But GAAP Results Showed an $856 Million Net Loss Avis Budget Group Told Investors Adjusted EBITDA Rose 11% -- But GAAP Results Showed an $8
CAR INVESTORS LOSE BIG ON Q4 EARNINGS MISS -- LEVI & KORSINSKY, LLP INVESTIGATES
02:15pm, Wednesday, 04'th Mar 2026
Avis Budget Group Posts $856 Million Net Loss as Revenue Falls Short of Expectations NEW YORK, March 4, 2026 /PRNewswire/ -- Avis Budget Group (NASDAQ: CAR) shareholders suffered significant losses af
Topline data of investigator‑initiated study at the University of Minnesota and City of Hope demonstrates 86% overall response rate (OR), including 57% complete response (CR) and 29% partial respons
Kyverna Therapeutics: The King Of The CAR-T Autoimmune Revolution
01:02am, Tuesday, 03'rd Mar 2026
Kyverna Therapeutics leads CAR-T therapy for autoimmune diseases, with KYV-101 showing unprecedented efficacy in SPS and MG registrational trials. KYTX's SPS trial achieved 81% clinically meaningful i
Carl Icahn and Other Insiders Are Doubling Down Amid Market Volatilities
07:55am, Monday, 02'nd Mar 2026
Insider buying can signal confidence when executives and major shareholders put their own money on the line.
Philadelphia, Pennsylvania--(Newsfile Corp. - March 1, 2026) - Kaskela Law LLC announces that it is actively investigating the recently announced proposed buyout of Mister Car Wash, Inc. (NASDAQ: MCW)
